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this interesting case is the first report of the occurrence of proteinuria in a child with
Castleman disease.
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Purpose:Primary intracranial rhabdomyosarcoma (RMS) is a rare tumor in childhood
that is found in various locations in the central nervous system. This report presents
such a case.
Method:This 6 year old boy presented with severe headache, emesis, and double
vision. On examination, left 6th and 7th cranial nerve palsy was noted. MRI revealed a
temporal mass extending to frontal lobe, basal ganglia, sylvian fissure and
obliterating the left ventricle. The patient underwent a left frontotemporal
craniotomy with gross total tumor resection. The pathological diagnosis was
embryonal RMS. Postoperatif MRI revealed left hipocampal residual nodule.
Computerized tomography (CT) of chest showed metastatic nodules in both lungs.
Radiation therapy with a dose of 54 Gy was applied to whole brain. He concurrently
received chemotherapy consisting of ifosfamide, carboplatin and etoposide. At the end
of induction chemotherapy, CT revealed considerable resolution of the lung metastasis
and also MRI revealed resolution of the hipocampal residual nodule. After 6 months of
remission period, cranial MRI revealed recurrence of the hipocampal nodul. Total re-
excision of tumor was performed and histopathological examination revealed
embryonal RMS. Post-operative MRI revealed a new periventricular lesion. MRI-
Spectroscopy also supported this finding. A regimen of chemotherapy including
intravenous vincristine, cyclophosphamide, adriamycin and cisplatin and intrathecal
methotrexate, cytosine arabinoside and prednisolon was administered. Under
chemotherapy, cervical lymph node metastasis was detected. Patient’s family rejected
further treatment and he is still alive with progresive disease after 30 months of
diagnosis.
Results:Primary RMS of the central nervous system (CNS) is rare in children. The
outcome in the majority of cases is poor and many cases are associated with early
mortality as in our case Conclusion: In spite of advances in the treatment of RMS,
primary brain localization has still very poor prognosis. Novel approaches for
treatment of special localizations are required.
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Purpose:A 3 years old boy presented with headache, ocular pain, prominent frontal
veins, irritability and occasional vomiting.
Method:Clinical examination revealed turgescent frontal veins, marked
exophtalmos, moderate hepatomegaly and congested retinal veins on fundoscopy.
Results:Thromboses of the sagittal, transverse and sigmoid sinuses were confirmed
on cranial MRI. Leukoencephalopathy compatible with either chronic venous
hypertension or LCH-CNS involvement was also noted. Biology showed elevated
sedimentation rate (ESR), microcytic anemia, leucopenia and slightly elevated
triglycerides. A comprehensive thrombophilia work-up including antithrombinIII,
protein C/S, Factor VLeiden/Prothrombin mutations, homocystein level and
antiphospholipid antibodies was negative. Fibrinogen, sCD25 and TNFalpha were
elevated.Radiology showed multiple osteolytic lesions of the scalp, ribs, pelvis and
inferior extremities. Histology of a lesion revealed CD1a-positive dendritic cells with
Birbeck granules. Bone marrow was hypercellular with focal histiocytic proliferation
and hemophagocytosis. MS-LCH with secondary HLH was diagnosed. Subcutaneous
LMWH and chemotherapy according to LCH-III protocol were started. Reevaluation
after 6 weeks showed partial reopening of cerebral thromboses and lower ESR but
otherwise persisting disease activity. After re-induction as per protocol no further
clinical, biological or radiological benefit could be achieved and we proceeded to
salvage therapy for refractory MS-LCH (LCH-S-2005) combining HDAra-C and
2-CDA. After the first course, the patient developed an asymptomatic thrombus
of the roof of the right atrium, unrelated to the central venous catheter. Full
UFH-anticoagulation remaining unsuccessful, surgical removal of the thrombus under
extra-corporeal circulation was performed. Microscopic examination revealed
lymphoplasmocytic-histiocytic inflammatory infiltrates negative for S100 and CD1a.
A second thrombophilic work-up remained unremarkable.
Conclusion:To our knowledge, this is the first description of such significant
thrombotic events in a child with MS-LCH. Common inherited and acquired
predisposing factors were excluded and we hypothesize that the multiple thromboses
observed might be secondary to the activation of dendritic cells and cytokine release
described in histiocytoses and acute inflammatory diseases.
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